A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com India
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook Investing.com India
Thermo Fisher prices €2.1 billion notes offering in two tranches - Investing.com
Thermo Fisher prices €2.1 billion notes offering in two tranches Investing.com
Agilent Q4 2025 slides: Revenue beats guidance for sixth straight quarter - Investing.com
Agilent Q4 2025 slides: Revenue beats guidance for sixth straight quarter Investing.com
After-hours movers: Zoom, Agilent, Symbotic By Investing.com - Investing.com South Africa
After-hours movers: Zoom, Agilent, Symbotic By Investing.com Investing.com South Africa
After-hours movers: Zoom, Agilent, Symbotic - Investing.com
After-hours movers: Zoom, Agilent, Symbotic Investing.com
After-hours movers: Zoom, Agilent, Symbotic By Investing.com - Investing.com UK
After-hours movers: Zoom, Agilent, Symbotic By Investing.com Investing.com UK
Agilent stock edges lower post Q4 print By Investing.com - Investing.com South Africa
Agilent stock edges lower post Q4 print By Investing.com Investing.com South Africa
Agilent Technologies earnings beat by $0.01, revenue topped estimates By Investing.com - Investing.com Nigeria
Agilent Technologies earnings beat by $0.01, revenue topped estimates By Investing.com Investing.com Nigeria
Roche expands Veeva partnership with AI-enabled CRM adoption By Investing.com - Investing.com Australia
Roche expands Veeva partnership with AI-enabled CRM adoption By Investing.com Investing.com Australia
10X Genomics stock hits 52-week high at 17.7 USD By Investing.com - Investing.com Nigeria
10X Genomics stock hits 52-week high at 17.7 USD By Investing.com Investing.com Nigeria
Agilent declares 25.5 cents quarterly dividend payable in January - Investing.com
Agilent declares 25.5 cents quarterly dividend payable in January Investing.com
10x Genomics at Wolfe Research Healthcare: Navigating Challenges and Opportunities - Investing.com
10x Genomics at Wolfe Research Healthcare: Navigating Challenges and Opportunities Investing.com
10x Genomics stock hits 52-week high at 17.26 USD - Investing.com
10x Genomics stock hits 52-week high at 17.26 USD Investing.com
10X Genomics earnings beat by $0.07, revenue topped estimates - Investing.com
10X Genomics earnings beat by $0.07, revenue topped estimates Investing.com
Thermo Fisher Scientific declares $0.43 quarterly dividend - Investing.com
Thermo Fisher Scientific declares $0.43 quarterly dividend Investing.com
Thermo Fisher Scientific beats Q3 expectations as revenue rises 5% - Investing.com
Thermo Fisher Scientific beats Q3 expectations as revenue rises 5% Investing.com
Waters Corporation stock hits 52-week low at 279.51 USD - Investing.com
Waters Corporation stock hits 52-week low at 279.51 USD Investing.com
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 - Investing.com
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 Investing.com
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page